Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.

Wu QW, Yang QM, Huang YF, She HQ, Liang J, Yang QL, Zhang ZM.

PLoS One. 2014 May 20;9(5):e97804. doi: 10.1371/journal.pone.0097804. eCollection 2014.

PMID:
24845596
[PubMed - in process]
Free PMC Article
2.

Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.

Wu QW, She HQ, Liang J, Huang YF, Yang QM, Yang QL, Zhang ZM.

BMC Cancer. 2012 Jan 27;12:47. doi: 10.1186/1471-2407-12-47.

PMID:
22284579
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer.

Ding M, Fu X, Tan H, Wang R, Chen Z, Ding S.

Mol Med Rep. 2012 Nov;6(5):1023-9. doi: 10.3892/mmr.2012.1043. Epub 2012 Aug 21.

PMID:
22923155
[PubMed - indexed for MEDLINE]
4.

Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.

Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X.

BMC Cancer. 2008 Mar 28;8:83. doi: 10.1186/1471-2407-8-83.

PMID:
18373849
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].

Xie XD, Qu SX, Zheng ZD, Song FL, Liu DW.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):356-60. Chinese.

PMID:
18953835
[PubMed - indexed for MEDLINE]
6.

[Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].

Fan YZ, Li GM, Huang GP, Li XP.

Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Nov;9(6):477-82. Chinese.

PMID:
17143789
[PubMed - indexed for MEDLINE]
7.

Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis.

Wu Q, Zheng Y, Chen D, Li X, Lu C, Zhang Z.

J Surg Res. 2014 May 15;188(2):459-65. doi: 10.1016/j.jss.2014.01.058. Epub 2014 Feb 4.

PMID:
24612949
[PubMed - indexed for MEDLINE]
Free Article
8.

[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].

Zheng SQ, Huang RQ, Zhang YJ.

Zhonghua Bing Li Xue Za Zhi. 2010 Apr;39(4):240-4. Chinese.

PMID:
20654122
[PubMed - indexed for MEDLINE]
9.

Elevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancer.

Lu LS, Chen L, Ding WX, Li K, Wu JJ.

Eur Rev Med Pharmacol Sci. 2012 Dec;16(15):2037-43.

PMID:
23280016
[PubMed - indexed for MEDLINE]
Free Article
10.

Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.

Heo DS, Choi H, Yeom MY, Song BJ, Oh SJ.

Oncol Rep. 2014 Apr;31(4):1567-72. doi: 10.3892/or.2014.3001. Epub 2014 Jan 27.

PMID:
24481627
[PubMed - in process]
11.

Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.

Zhao YC, Ni XJ, Li Y, Dai M, Yuan ZX, Zhu YY, Luo CY.

World J Surg Oncol. 2012 Aug 20;10:165. doi: 10.1186/1477-7819-10-165.

PMID:
22906075
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].

Zhang B, Liu YX, Cao WF, Cao XC, Ning LS, Hao XS.

Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):471-6. Chinese.

PMID:
19035119
[PubMed - indexed for MEDLINE]
13.

[Relationship and clinical significance of KiSS-1, nuclear factor kappa B (NF-kappaB), p50, and matrix metalloproteinase 9 expression in breast cancer].

Yi X, Li CY, Zhang SH, Wang XH, Li ZQ, Yang F.

Zhonghua Bing Li Xue Za Zhi. 2008 Apr;37(4):238-42. Chinese.

PMID:
18844032
[PubMed - indexed for MEDLINE]
14.

A meta-analysis of the relationship between lymphatic microvessel density and clinicopathological parameters in breast cancer.

Chen Y, Yan J, Yuan Z, Yu S, Yang C, Wang Z, Zheng Q.

Bull Cancer. 2013 Mar;100(3):1-10. doi: 10.1684/bdc.2013.1719. Review.

PMID:
23501839
[PubMed - indexed for MEDLINE]
15.

Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.

Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN.

Mod Pathol. 2005 Jan;18(1):143-52.

PMID:
15297858
[PubMed - indexed for MEDLINE]
Free Article
16.

Association of chemotactic factor receptor 5 gene with breast cancer.

Zhang Y, Meng FY, Li WL, Zhou CX, Guan Z, Fan HY.

Genet Mol Res. 2013 Nov 7;12(4):5289-300. doi: 10.4238/2013.November.7.4.

PMID:
24301790
[PubMed - in process]
Free Article
17.

Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.

Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R, Birner P.

Breast Cancer Res Treat. 2006 Sep;99(2):135-41. Epub 2006 Mar 23.

PMID:
16555123
[PubMed - indexed for MEDLINE]
18.

Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE.

Int J Mol Med. 2006 Apr;17(4):583-90.

PMID:
16525713
[PubMed - indexed for MEDLINE]
19.
20.

[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].

Fan SQ, Wei QY, Li MR, Zhang LQ, Liang QC.

Ai Zheng. 2003 Sep;22(9):968-73. Chinese.

PMID:
12969531
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk